NPCE NeuroPace, Inc.

NASDAQ
$14.06

NeuroPace, Inc. (NPCE) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.7% since its last earnings release on August 11, 2026.

NeuroPace Beat Consensus Estimates, Raises Guidance, but Remains In-line with Estimates
Tuesday, August 11, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.14)
Rev est $26.78M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $14.44

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About NeuroPace, Inc.

NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.